Robert S Zeiger
Overview
Explore the profile of Robert S Zeiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
218
Citations
5326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanz M, Chipps B, Zeiger R, Bacharier L, Guilbert T, Murphy K, et al.
Ann Allergy Asthma Immunol
. 2024 Nov;
134(2):198-208.e2.
PMID: 39615584
Background: Asthma in children is a leading cause of missed school days, emergency department visits, and hospitalizations. Approximately 40% of children with asthma experience uncontrolled disease and annual exacerbations. There...
2.
Zeiger R, Tse K, Li Q, Saparudin M, Al-Salman S, Puttock E, et al.
J Allergy Clin Immunol Pract
. 2024 Oct;
13(1):202-212.e7.
PMID: 39477015
Background: Indolent systemic mastocytosis (ISM), the most frequent subtype of systemic mastocytosis, requires better understanding. Objective: To better understand the diagnostic journey, symptom severity, impact on quality of life and...
3.
Tse K, Chen W, Puttock E, Chowdhury S, Miller K, Powell D, et al.
J Allergy Clin Immunol Glob
. 2024 Sep;
3(4):100316.
PMID: 39234417
Background: Systemic mastocytosis (SM), a rare condition affecting about 32,000 individuals in the United States, is often misdiagnosed or underdiagnosed owing to its nonspecific symptoms and the need for invasive...
4.
Xu S, Puttock E, Zeiger R, Vollmer W, Schatz M, Crawford W, et al.
J Allergy Clin Immunol Pract
. 2024 Aug;
12(11):2966-2974.e11.
PMID: 39147276
Background: Social determinants of health have a significant impact on asthma outcomes, and factors such as income level and neighborhood environment have crucial roles. Objective: This study aimed to assess...
5.
Chipps B, Zeiger R, Beuther D, Wise R, McCann W, Reibman J, et al.
J Asthma Allergy
. 2024 Aug;
17:751-756.
PMID: 39131600
No abstract available.
6.
Horner A, Land M, Abolhosn R, Stern J, Pandya S, Lagier R, et al.
Ann Allergy Asthma Immunol
. 2024 Jul;
133(4):445-452.e5.
PMID: 38969008
Background: The peanut basophil activation test (BAT) has demonstrated excellent diagnostic accuracy with heparinized blood, but its clinical utility is limited by the short stability of samples stored in this...
7.
Zeiger J, Silvers W, Zeiger R
Ann Allergy Asthma Immunol
. 2024 Jun;
133(3):344-345.
PMID: 38879163
No abstract available.
8.
Chen W, Puttock E, Schatz M, Crawford W, Vollmer W, Xie F, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(10):2705-2716.e6.
PMID: 38821437
Background: Although individuals with mild asthma account for 30% to 40% of acute asthma exacerbations (AAEs), relatively little attention has been paid to risk factors for AAEs in this population....
9.
Murphy K, Beuther D, Chipps B, Wise R, McCann W, Reibman J, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(8):2092-2101.e4.
PMID: 38705273
Background: Complex models combining impairment-based control assessments with clinical characteristics and biomarkers have been developed to predict asthma exacerbations. The composite Asthma Impairment and Risk Questionnaire (AIRQ) with adjustments for...
10.
Zeiger R, Schatz M, Pomichowski M, Li Q, Slezak J, Nolte H, et al.
J Allergy Clin Immunol Glob
. 2024 May;
3(3):100250.
PMID: 38699651
Background: Sublingual immunotherapy (SLIT) with 12 SQ house dust mile SLIT-tablet (HDM SLIT-tablet) for dust mite-induced perennial allergic rhinitis is reported as effective and safe. Although serious allergic reactions (SARs)...